PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 3, 2001Circulation Research193 citationsOpen Access

Phenotypic Modulation of Vascular Smooth Muscle Cells Induced by Unsaturated Lysophosphatidic Acids

View Full Paper
KHKen’ichiro HayashiMTMasanori TakahashiWNWataru Nishida

Key Points

Key points are not available for this paper at this time.

Abstract

The phenotypic modulation of vascular smooth muscle cells (VSMCs) from the differentiated state to the dedifferentiated one is critically involved in the development and progression of atherosclerosis. Although many cytokines and growth factors have been reported as atherogenic factors, the critical pathogens for inducing atherosclerosis remain unknown, largely because proper examining systems of them have not been developed. We recently established primary culture systems for visceral SMCs and VSMCs in which both SMCs, when cultured on laminin with insulin-like growth factor-I, show a differentiated phenotype, as indicated by a spindle-like shape, ligand-induced contractility, and a high level of SMC differentiation marker gene expression. In this study, we searched for critical dedifferentiation factors for these SMCs using our culture system. We found that polar lipids extracted from human serum markedly induced VSMC dedifferentiation, and this activity was solely present in the lysophosphatidic acid (LPA) fraction. Among several LPA species detected in human serum lipids, unsaturated LPAs were identified as major contributors to the induction of VSMC dedifferentiation. Signaling and phenotype analyses revealed that unsaturated LPA-induced VSMC dedifferentiation is mediated through the coordinated activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase. Thus, this report demonstrates the first finding that unsaturated LPAs, but not saturated LPAs, specifically induce VSMC phenotypic modulation, suggesting that these molecules could function as atherogenic factors.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hayashi et al. (2001) studied this question.

synapsesocial.com/papers/6a70dd1a5671bbf00bc2c9c0https://doi.org/10.1161/hh1501.094265
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION1959 · 23,111 citations
  2. 2Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions1999 · 405 citations
  3. 3Lysophosphatidic acid stimulates protein kinase C isoforms α, β, ɛ, and ζ in a pertussis toxin sensitive pathway in vascular smooth muscle cells1999 · 34 citations
  4. 4Pharmacological Characterization of Phospholipid Growth‐Factor Receptors2000 · 21 citations
  5. 5Characterization of a Novel Subtype of Human G Protein-coupled Receptor for Lysophosphatidic Acid1998 · 538 citations